preadipocyte-targeting monoclonal antibodies (Abeome)

N/A

Report date: 2025/03/20 10:11:41

Base Information

Drug Namepreadipocyte-targeting monoclonal antibodies (Abeome)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsObesityDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAbeome Corp
China Registration ClassN/A

Develop Information

Active CompaniesAbeome Corp
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A